Skip to main content
Clinical Trials/IRCT20210212050334N2
IRCT20210212050334N2
Not yet recruiting
Phase 1

Evaluation of safety and efficacy of stromal vascular fraction on foot diabetic wound-clinical trial phase I and II

Rasht University of Medical Sciences0 sites62 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Rasht University of Medical Sciences
Enrollment
62
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Rasht University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Having chronic outpatient diabetic foot ulcer
  • Age range from 30 to 60 years
  • Having a single wound on the foot and limb terminals (fingers, sole, heel, toes) within four works without repair
  • Body Mass index 18\-25
  • ABI / TBI ratio greater than 0\.9\.

Exclusion Criteria

  • Alcohol consumption
  • Drug addiction
  • Taking drugs that may interfere with wound healing, such as corticosteroids, immunosuppressive agents, and cytotoxic agents.
  • A concomitant disease that may interfere with wound healing, such as cancer, vasculitis, kidney, liver, or heart failure.
  • Osteomyelitis

Outcomes

Primary Outcomes

Not specified

Similar Trials